Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Frank Buttgereit, N. Caeyers et al.|Annals of the Rheumatic Diseases|2016Cited by 331
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren’s syndromeM. Jasiek, Benjamin Terrier, Alexandre Karras et al.|Lara D. Veeken|2016Cited by 79